Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Advancing Translational Science for Pulmonary NTM Infections: A Roadmap for Research.

Daniel-Wayman S, Abate G, Barber DL, Bermudez LE, Coler RN, Cynamon MH, Daley CL, Davidson RM, Dick T, Floto RA, Henkle E, Holland SM, Jackson M, Lee RE, Nuermberger EL, Olivier KN, Ordway DJ, Prevots DR, Sacchettini JC, Salfinger M, Sassetti CM, Sizemore CF, Winthrop KL, Zelazny AM.

Am J Respir Crit Care Med. 2018 Nov 14. doi: 10.1164/rccm.201807-1273PP. [Epub ahead of print]

PMID:
30428263
2.

Hospital-based antibiotic use in patients with Mycobacterium avium complex.

Ricotta EE, Olivier KN, Lai YL, Prevots DR, Adjemian J.

ERJ Open Res. 2018 Nov 2;4(4). pii: 00109-2018. doi: 10.1183/23120541.00109-2018. eCollection 2018 Oct.

3.

ALIS (Amikacin Liposome Inhalation Suspension): The Beginning of a Wonderland?

Daley CL, Olivier KN.

Am J Respir Crit Care Med. 2018 Oct 26. doi: 10.1164/rccm.201810-1901ED. [Epub ahead of print] No abstract available.

PMID:
30365392
4.

Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.

Flume PA, Chalmers JD, Olivier KN.

Lancet. 2018 Sep 8;392(10150):880-890. doi: 10.1016/S0140-6736(18)31767-7. Review.

PMID:
30215383
5.

Sarcoidosis-Associated Hospitalizations in the United States, 2002-2012.

Wills AB, Adjemian JA, Fontana JR, Steiner CA, Daniel-Wayman S, Olivier KN, Prevots DR.

Ann Am Thorac Soc. 2018 Sep 10. doi: 10.1513/AnnalsATS.201806-401RL. [Epub ahead of print] No abstract available.

PMID:
30199648
6.

Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline.

Shapiro AJ, Davis SD, Polineni D, Manion M, Rosenfeld M, Dell SD, Chilvers MA, Ferkol TW, Zariwala MA, Sagel SD, Josephson M, Morgan L, Yilmaz O, Olivier KN, Milla C, Pittman JE, Daniels MLA, Jones MH, Janahi IA, Ware SM, Daniel SJ, Cooper ML, Nogee LM, Anton B, Eastvold T, Ehrne L, Guadagno E, Knowles MR, Leigh MW, Lavergne V; American Thoracic Society Assembly on Pediatrics.

Am J Respir Crit Care Med. 2018 Jun 15;197(12):e24-e39. doi: 10.1164/rccm.201805-0819ST.

PMID:
29905515
7.

Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014.

Adjemian J, Olivier KN, Prevots DR.

Ann Am Thorac Soc. 2018 Jul;15(7):817-826. doi: 10.1513/AnnalsATS.201709-727OC.

PMID:
29897781
8.

Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement.

van Ingen J, Aksamit T, Andrejak C, Böttger EC, Cambau E, Daley CL, Griffith DE, Guglielmetti L, Holland SM, Huitt GA, Koh WJ, Lange C, Leitman P, Marras TK, Morimoto K, Olivier KN, Santin M, Stout JE, Thomson R, Tortoli E, Wallace RJ Jr, Winthrop KL, Wagner D; for NTM-NET.

Eur Respir J. 2018 Mar 22;51(3). pii: 1800170. doi: 10.1183/13993003.00170-2018. Print 2018 Mar. No abstract available.

PMID:
29567726
9.

Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis.

Abadie ME, Strich JR, Kim T, Xie YL, Fennelly KP, Olivier KN, Waldman M, Arora K, Holland SM, Chen RY.

Eur Respir J. 2017 Dec 28;50(6). pii: 1702023. doi: 10.1183/13993003.02023-2017. Print 2017 Dec. No abstract available.

PMID:
29284688
10.

Survival of pathogenic Mycobacterium abscessus subsp. massiliense in Acanthamoeba castellanii.

da Silva JL, Nguyen J, Fennelly KP, Zelazny AM, Olivier KN.

Res Microbiol. 2018 Jan;169(1):56-60. doi: 10.1016/j.resmic.2017.10.001. Epub 2017 Oct 19.

PMID:
29056478
11.

Transcriptional Response of Respiratory Epithelium to Nontuberculous Mycobacteria.

Matsuyama M, Martins AJ, Shallom S, Kamenyeva O, Kashyap A, Sampaio EP, Kabat J, Olivier KN, Zelazny AM, Tsang JS, Holland SM.

Am J Respir Cell Mol Biol. 2018 Feb;58(2):241-252. doi: 10.1165/rcmb.2017-0218OC.

PMID:
28915071
12.

Geographic Distribution of Nontuberculous Mycobacterial Species Identified among Clinical Isolates in the United States, 2009-2013.

Spaulding AB, Lai YL, Zelazny AM, Olivier KN, Kadri SS, Prevots DR, Adjemian J.

Ann Am Thorac Soc. 2017 Nov;14(11):1655-1661. doi: 10.1513/AnnalsATS.201611-860OC.

13.

Whole-Exome Sequencing Identifies the 6q12-q16 Linkage Region and a Candidate Gene, TTK, for Pulmonary Nontuberculous Mycobacterial Disease.

Chen F, Szymanski EP, Olivier KN, Liu X, Tettelin H, Holland SM, Duggal P.

Am J Respir Crit Care Med. 2017 Dec 15;196(12):1599-1604. doi: 10.1164/rccm.201612-2479OC.

PMID:
28777004
14.

Frequency of untreated hypogammaglobulinemia in bronchiectasis.

Ruffner MA, Aksamit TR, Thomashow B, Choate R, DiMango A, Turino GM, O'Donnell AE, Johnson MM, Olivier KN, Fennelly K, Daley CL, Winthrop KL, Metersky ML, Salathe MA, Knowles MR, Daniels MLA, Noone PG, Tino G, Griffith DE, Sullivan KE.

Ann Allergy Asthma Immunol. 2017 Jul;119(1):83-85. doi: 10.1016/j.anai.2017.04.020. Epub 2017 May 20. No abstract available.

PMID:
28539185
15.

Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry.

Henkle E, Aksamit TR, Barker AF, Curtis JR, Daley CL, Anne Daniels ML, DiMango A, Eden E, Fennelly K, Griffith DE, Johnson M, Knowles MR, Leitman A, Leitman P, Malanga E, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Prieto D, Salathe M, Thomashow B, Tino G, Turino G, Wisclenny S, Winthrop KL.

Chest. 2017 Dec;152(6):1120-1127. doi: 10.1016/j.chest.2017.04.167. Epub 2017 May 5.

PMID:
28479113
16.

MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections.

McCormack RM, Szymanski EP, Hsu AP, Perez E, Olivier KN, Fisher E, Goodhew EB, Podack ER, Holland SM.

JCI Insight. 2017 Apr 20;2(8). pii: 89635. doi: 10.1172/jci.insight.89635. [Epub ahead of print]

17.

Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring.

Liu C, Zhao Z, Fan J, Lyon CJ, Wu HJ, Nedelkov D, Zelazny AM, Olivier KN, Cazares LH, Holland SM, Graviss EA, Hu Y.

Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3969-3974. doi: 10.1073/pnas.1621360114. Epub 2017 Mar 27.

18.

Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA.

Adjemian J, Frankland TB, Daida YG, Honda JR, Olivier KN, Zelazny A, Honda S, Prevots DR.

Emerg Infect Dis. 2017 Mar;23(3):439-447. doi: 10.3201/eid2303.161827.

19.

Pneumocystis colonization in asthmatic patients not receiving oral corticosteroid therapy.

Davey EL, Colombo RE, Fiorentino C, Fahle G, Davey RT Jr, Olivier KN, Kovacs JA.

J Investig Med. 2017 Apr;65(4):800-802. doi: 10.1136/jim-2016-000381. Epub 2017 Feb 13.

PMID:
28193704
20.

Respiratory manifestations in 38 patients with Alström syndrome.

Boerwinkle C, Marshall JD, Bryant J, Gahl WA, Olivier KN, Gunay-Aygun M.

Pediatr Pulmonol. 2017 Apr;52(4):487-493. doi: 10.1002/ppul.23607. Epub 2016 Dec 28.

PMID:
28029746
21.

Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry.

Aksamit TR, O'Donnell AE, Barker A, Olivier KN, Winthrop KL, Daniels MLA, Johnson M, Eden E, Griffith D, Knowles M, Metersky M, Salathe M, Thomashow B, Tino G, Turino G, Carretta B, Daley CL; Bronchiectasis Research Registry Consortium.

Chest. 2017 May;151(5):982-992. doi: 10.1016/j.chest.2016.10.055. Epub 2016 Nov 23.

22.

Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiency.

Kuhns DB, Fink DL, Choi U, Sweeney C, Lau K, Priel DL, Riva D, Mendez L, Uzel G, Freeman AF, Olivier KN, Anderson VL, Currens R, Mackley V, Kang A, Al-Adeli M, Mace E, Orange JS, Kang E, Lockett SJ, Chen, Steinbach PJ, Hsu AP, Zarember KA, Malech HL, Gallin JI, Holland SM.

Blood. 2016 Oct 27;128(17):2135-2143. Epub 2016 Aug 24.

23.

Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.

Olivier KN, Griffith DE, Eagle G, McGinnis JP 2nd, Micioni L, Liu K, Daley CL, Winthrop KL, Ruoss S, Addrizzo-Harris DJ, Flume PA, Dorgan D, Salathe M, Brown-Elliott BA, Gupta R, Wallace RJ Jr.

Am J Respir Crit Care Med. 2017 Mar 15;195(6):814-823. doi: 10.1164/rccm.201604-0700OC.

24.

Lady Windermere Dissected: More Form Than Fastidious.

Olivier KN.

Ann Am Thorac Soc. 2016 Oct;13(10):1674-1676. No abstract available.

25.

Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report.

Henkle E, Aksamit T, Barker A, Daley CL, Griffith D, Leitman P, Leitman A, Malanga E, Marras TK, Olivier KN, Prevots DR, Prieto D, Quittner AL, Skach W, Walsh JW, Winthrop KL; NTMRC Patient Advisory Panel.

Ann Am Thorac Soc. 2016 Sep;13(9):S379-84. doi: 10.1513/AnnalsATS.201605-387WS.

26.

Mediastinal and Disseminated Mycobacterium kansasii Disease in GATA2 Deficiency.

Lovell JP, Zerbe CS, Olivier KN, Claypool RJ, Frein C, Anderson VL, Freeman AF, Holland SM.

Ann Am Thorac Soc. 2016 Dec;13(12):2169-2173.

27.

Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Ferre EM, Rose SR, Rosenzweig SD, Burbelo PD, Romito KR, Niemela JE, Rosen LB, Break TJ, Gu W, Hunsberger S, Browne SK, Hsu AP, Rampertaap S, Swamydas M, Collar AL, Kong HH, Lee CR, Chascsa D, Simcox T, Pham A, Bondici A, Natarajan M, Monsale J, Kleiner DE, Quezado M, Alevizos I, Moutsopoulos NM, Yockey L, Frein C, Soldatos A, Calvo KR, Adjemian J, Similuk MN, Lang DM, Stone KD, Uzel G, Kopp JB, Bishop RJ, Holland SM, Olivier KN, Fleisher TA, Heller T, Winer KK, Lionakis MS.

JCI Insight. 2016 Aug 18;1(13). pii: e88782.

28.

Hyper-IgE Syndromes and the Lung.

Freeman AF, Olivier KN.

Clin Chest Med. 2016 Sep;37(3):557-67. doi: 10.1016/j.ccm.2016.04.016. Epub 2016 Jun 10. Review.

29.

Exercise-induced haemoptysis as a rare presentation of a rare lung disease.

Mihalek AD, Haney C, Merino M, Roy-Chowdhuri S, Moss J, Olivier KN.

Thorax. 2016 Sep;71(9):865-8. doi: 10.1136/thoraxjnl-2015-208020. Epub 2016 Jun 7.

PMID:
27272655
30.

Pulmonary Manifestations of the Autoimmune Lymphoproliferative Syndrome. A Retrospective Study of a Unique Patient Cohort.

Lau CY, Mihalek AD, Wang J, Dodd LE, Perkins K, Price S, Webster S, Pittaluga S, Folio LR, Rao VK, Olivier KN.

Ann Am Thorac Soc. 2016 Aug;13(8):1279-88. doi: 10.1513/AnnalsATS.201601-079OC.

31.

Mortality among patients with pulmonary non-tuberculous mycobacteria disease.

Fleshner M, Olivier KN, Shaw PA, Adjemian J, Strollo S, Claypool RJ, Folio L, Zelazny A, Holland SM, Prevots DR.

Int J Tuberc Lung Dis. 2016 May;20(5):582-7. doi: 10.5588/ijtld.15.0807.

PMID:
27084809
32.

Clinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Children and Adolescents.

Leigh MW, Ferkol TW, Davis SD, Lee HS, Rosenfeld M, Dell SD, Sagel SD, Milla C, Olivier KN, Sullivan KM, Zariwala MA, Pittman JE, Shapiro AJ, Carson JL, Krischer J, Hazucha MJ, Knowles MR.

Ann Am Thorac Soc. 2016 Aug;13(8):1305-13. doi: 10.1513/AnnalsATS.201511-748OC.

33.

Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis.

Song T, Lee M, Jeon HS, Park Y, Dodd LE, Dartois V, Follman D, Wang J, Cai Y, Goldfeder LC, Olivier KN, Xie Y, Via LE, Cho SN, Barry CE 3rd, Chen RY.

EBioMedicine. 2015 Oct 9;2(11):1627-33. doi: 10.1016/j.ebiom.2015.09.051. eCollection 2015 Nov.

34.

Micro-CT scouting for transmission electron microscopy of human tissue specimens.

Morales AG, Stempinski ES, Xiao X, Patel A, Panna A, Olivier KN, McShane PJ, Robinson C, George AJ, Donahue DR, Chen P, Wen H.

J Microsc. 2016 Jul;263(1):113-7. doi: 10.1111/jmi.12385. Epub 2016 Feb 8.

35.

A phase 1 randomized, double-blind, placebo-controlled, crossover trial of DAS181 (Fludase®) in adult subjects with well-controlled asthma.

Colombo RE, Fiorentino C, Dodd LE, Hunsberger S, Haney C, Barrett K, Nabha L, Davey RT Jr, Olivier KN.

BMC Infect Dis. 2016 Feb 1;16:54. doi: 10.1186/s12879-016-1358-9.

36.

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary.

Floto RA, Olivier KN, Saiman L, Daley CL, Herrmann JL, Nick JA, Noone PG, Bilton D, Corris P, Gibson RL, Hempstead SE, Koetz K, Sabadosa KA, Sermet-Gaudelus I, Smyth AR, van Ingen J, Wallace RJ, Winthrop KL, Marshall BC, Haworth CS.

Thorax. 2016 Jan;71(1):88-90. doi: 10.1136/thoraxjnl-2015-207983.

37.

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.

Floto RA, Olivier KN, Saiman L, Daley CL, Herrmann JL, Nick JA, Noone PG, Bilton D, Corris P, Gibson RL, Hempstead SE, Koetz K, Sabadosa KA, Sermet-Gaudelus I, Smyth AR, van Ingen J, Wallace RJ, Winthrop KL, Marshall BC, Haworth CS; US Cystic Fibrosis Foundation and European Cystic Fibrosis Society.

Thorax. 2016 Jan;71 Suppl 1:i1-22. doi: 10.1136/thoraxjnl-2015-207360.

38.

Reply: Cure Not Possible, by Definition.

Griffith DE, Adjemian J, Brown-Elliott BA, Prevots DR, Philley JV, Olivier KN, Wallace RJ Jr.

Am J Respir Crit Care Med. 2015 Nov 15;192(10):1256-7. doi: 10.1164/rccm.201508-1515LE. No abstract available.

39.

Beyond Marfan: the clinical impact of bronchiectasis and non-tuberculous mycobacteria in connective tissue diseases.

Leung JM, Olivier KN, Prevots DR, McDonnell NB.

Int J Tuberc Lung Dis. 2015 Nov;19(11):1409. doi: 10.5588/ijtld.15.0597. No abstract available.

PMID:
26467599
40.

Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review.

Shapiro AJ, Zariwala MA, Ferkol T, Davis SD, Sagel SD, Dell SD, Rosenfeld M, Olivier KN, Milla C, Daniel SJ, Kimple AJ, Manion M, Knowles MR, Leigh MW; Genetic Disorders of Mucociliary Clearance Consortium.

Pediatr Pulmonol. 2016 Feb;51(2):115-32. doi: 10.1002/ppul.23304. Epub 2015 Sep 29. Review.

41.

The association between sterilizing activity and drug distribution into tuberculosis lesions.

Prideaux B, Via LE, Zimmerman MD, Eum S, Sarathy J, O'Brien P, Chen C, Kaya F, Weiner DM, Chen PY, Song T, Lee M, Shim TS, Cho JS, Kim W, Cho SN, Olivier KN, Barry CE 3rd, Dartois V.

Nat Med. 2015 Oct;21(10):1223-7. doi: 10.1038/nm.3937. Epub 2015 Sep 7.

42.

Clonal Diversification and Changes in Lipid Traits and Colony Morphology in Mycobacterium abscessus Clinical Isolates.

Park IK, Hsu AP, Tettelin H, Shallom SJ, Drake SK, Ding L, Wu UI, Adamo N, Prevots DR, Olivier KN, Holland SM, Sampaio EP, Zelazny AM.

J Clin Microbiol. 2015 Nov;53(11):3438-47. doi: 10.1128/JCM.02015-15. Epub 2015 Aug 19.

43.

New Real-Time PCR Assays for Detection of Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Group.

Shallom SJ, Moura NS, Olivier KN, Sampaio EP, Holland SM, Zelazny AM.

J Clin Microbiol. 2015 Nov;53(11):3430-7. doi: 10.1128/JCM.01714-15. Epub 2015 Aug 12.

44.

Heme Oxygenase-1 Regulation of Matrix Metalloproteinase-1 Expression Underlies Distinct Disease Profiles in Tuberculosis.

Andrade BB, Pavan Kumar N, Amaral EP, Riteau N, Mayer-Barber KD, Tosh KW, Maier N, Conceição EL, Kubler A, Sridhar R, Banurekha VV, Jawahar MS, Barbosa T, Manganiello VC, Moss J, Fontana JR, Marciano BE, Sampaio EP, Olivier KN, Holland SM, Jackson SH, Moayeri M, Leppla S, Sereti I, Barber DL, Nutman TB, Babu S, Sher A.

J Immunol. 2015 Sep 15;195(6):2763-73. doi: 10.4049/jimmunol.1500942. Epub 2015 Aug 12.

45.

Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis.

Salsgiver EL, Fink AK, Knapp EA, LiPuma JJ, Olivier KN, Marshall BC, Saiman L.

Chest. 2016 Feb;149(2):390-400. doi: 10.1378/chest.15-0676. Epub 2016 Jan 12.

46.

Semiquantitative Culture Analysis during Therapy for Mycobacterium avium Complex Lung Disease.

Griffith DE, Adjemian J, Brown-Elliott BA, Philley JV, Prevots DR, Gaston C, Olivier KN, Wallace RJ Jr.

Am J Respir Crit Care Med. 2015 Sep 15;192(6):754-60. doi: 10.1164/rccm.201503-0444OC.

47.

Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease.

Szymanski EP, Leung JM, Fowler CJ, Haney C, Hsu AP, Chen F, Duggal P, Oler AJ, McCormack R, Podack E, Drummond RA, Lionakis MS, Browne SK, Prevots DR, Knowles M, Cutting G, Liu X, Devine SE, Fraser CM, Tettelin H, Olivier KN, Holland SM.

Am J Respir Crit Care Med. 2015 Sep 1;192(5):618-28. doi: 10.1164/rccm.201502-0387OC.

48.

Successful treatment of ulcerative bronchiolitis in a woman with refractory Mycobacterium intracellulare infection.

Egan JP 3rd, Seides BJ, Olivier KN, Addrizzo-Harris D.

BMJ Case Rep. 2015 Apr 29;2015. pii: bcr2015209604. doi: 10.1136/bcr-2015-209604.

49.

Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis.

Park IK, Olivier KN.

Semin Respir Crit Care Med. 2015 Apr;36(2):217-24. doi: 10.1055/s-0035-1546751. Epub 2015 Mar 31. Review.

PMID:
25826589
50.

"You can't always get what you want…" the Mycobacterium abscessus issue. Name versus function.

Zelazny AM, Olivier KN.

Ann Am Thorac Soc. 2015 Mar;12(3):300-2. doi: 10.1513/AnnalsATS.201502-087ED. No abstract available.

Supplemental Content

Loading ...
Support Center